• EZ Cap™ EGFP mRNA (5-moUTP): Next-Level mRNA Assay Precision

  2026-07-28

  Explore how EZ Cap EGFP mRNA 5-moUTP enables unparalleled mRNA delivery for gene expression studies, with a focus on translational efficiency and immune evasion. This article offers unique insights into mechanistic innovations and real-world assay optimization.

• LY-411575: Precision γ-Secretase Inhibition in Alzheimer’s a

  2026-07-27

  Explore how LY-411575, a potent gamma-secretase inhibitor, enables nuanced Alzheimer's disease and Notch signaling studies. This article uniquely dissects mechanistic insights, reference innovations, and practical applications beyond conventional summaries.

• Palmitic acid (Hexadecanoic acid): Protocol and Handling Gui

  2026-07-27

  Palmitic acid (SKU N2456) provides researchers with a high-purity, well-characterized saturated long-chain fatty acid for targeted studies in metabolic disorder research, inflammation signaling, and lipid metabolism pathways. It is not suitable for protocols requiring aqueous solubility or long-term solution storage, necessitating precise handling and immediate use after reconstitution.

• Estradiol–Autophagy Axis: Multi-Organ Protection in Perimeno

  2026-07-26

  This study uncovers how declining estradiol levels during perimenopause elevate the risk of metabolic and cardiovascular diseases via disruption of the estrogen receptor–autophagy axis. Using human cohort data, network pharmacology, and mouse models, the research delineates receptor- and autophagy-dependent pathways underlying estradiol's tissue-protective effects, providing mechanistic insights for hormone therapy strategies.

• CB-5083 and p97 Inhibition: Precision Disruption of Cellular

  2026-07-25

  Explore how CB-5083, a selective p97 inhibitor from APExBIO, is redefining experimental and translational strategies in oncology and protein homeostasis research. This article bridges mechanistic discoveries—such as ER stress signaling and ubiquitin ligase regulation—with practical guidance for researchers leveraging CB-5083, providing a forward-looking perspective on therapeutic targeting of proteostasis.

• Bufalin–CRISPR Nanomedicine: Reprogramming Immunity in CRC

  2026-07-24

  Liu et al. (2025) introduce a calcium lactate nanoparticle system co-delivering bufalin and CRISPR/Cas9 ribonucleoprotein for colorectal cancer immunotherapy. This innovation synergistically induces pyroptosis and apoptosis while reprogramming tumor-associated macrophages, offering a promising multimodal approach to overcome immunotherapy resistance.

• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode mRNA Delivery

  2026-07-24

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) empowers researchers to simultaneously visualize mRNA delivery and quantify translation efficiency with unmatched clarity. Its Cap1 capping, Cy5 labeling, and 5-moUTP modification together unlock robust, immune-silent workflows for both in vitro and in vivo applications.

• Sulfo-Cy5 Carboxylic Acid: Transforming In Vivo Fluorescence

  2026-07-23

  Discover how Sulfo-Cy5 carboxylic acid empowers advanced fluorescence imaging in life sciences. This article explores its role in in vivo nanoparticle tracking and mucosal immunity, revealing new frontiers in protein labeling and immunological assay design.

• Necrostatin-1: Strategic RIP1 Kinase Inhibition for Translat

  2026-07-23

  Necrostatin-1 (Nec-1) is a potent and selective RIP1 kinase inhibitor that has transformed the study of necroptosis, inflammation, and acute tissue injury in translational biomedical research. This article provides a mechanistic deep dive into RIP1-mediated necroptosis, explores validated experimental workflows, and delivers strategic guidance for maximizing Nec-1’s translational value. By bridging recent literature, including its application in overcoming drug resistance and optimizing necroptosis assays, this thought leadership piece advances the field beyond standard product overviews—empowering researchers to design rigorous, high-impact studies.

• gamma-Glu-Cys (γ-Glu-Cys): Protocols and Lab Use Guidance

  2026-07-22

  gamma-Glu-Cys (γ-Glu-Cys) is a high-purity substrate essential for glutathione metabolism research and thiol-reactive peptide synthesis workflows. It is not intended for diagnostic, clinical, or therapeutic use, and requires strict adherence to storage and handling protocols for reproducibility in enzymatic and plant adaptation assays.

• Strategic ROS Profiling: DCFH-DA as a Translational Benchmar

  2026-07-22

  This article synthesizes mechanistic insight and translational strategy for optimizing intracellular ROS detection using 2,7-Dichlorodihydrofluorescein diacetate (DCFH-DA). Anchored in the context of fibrosis and autophagy research, it offers actionable guidance on assay design, protocol parameters, and interpretation—bridging current translational needs with the evolving competitive landscape. The discussion highlights APExBIO's DCFH-DA product, integrates emerging evidence, and provides a forward-looking perspective for researchers advancing redox-based therapeutic discovery.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Real-Time Assay Excellence

  2026-07-21

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) delivers dual-fluorescence tracking and robust translation quantification, streamlining mRNA delivery optimization. Its Cap 1 structure and immune-evasive chemistry empower advanced gene regulation and function studies, setting a new benchmark for real-time, quantitative workflows.

• TFEB-Driven Lysosomal Biogenesis Blocks H1N1: Fangchinoline

  2026-07-21

  This study identifies fangchinoline as a potent modulator of TFEB-driven lysosomal biogenesis, restoring host antiviral capacity and blocking H1N1 influenza infection at the level of endolysosomal trafficking. The findings highlight the therapeutic potential of targeting lysosomal pathways in antiviral research and provide a methodology for discovering lysosome-targeted compounds.

• EZ Cap™ Cas9 mRNA (5-moUTP): Optimizing Neurodegeneration CR

  2026-07-20

  EZ Cap™ Cas9 mRNA (5-moUTP) empowers researchers to perform high-efficiency CRISPR-Cas9 genome editing with minimal immune activation, streamlining workflows in sensitive neurodegeneration models. Its advanced modifications and robust capping system enable reproducible functional gene studies and gene therapy research, even in challenging CNS contexts.

• Mechanisms of Polyether Ionophore Toxicity: Insights and Imp

  2026-07-20

  This review systematically examines the clinical and molecular mechanisms underlying polyether ionophore toxicity in animals, with a particular focus on how structural features mediate ion transport and cellular effects. The findings have direct implications for both veterinary safety and the rational repurposing of ionophores, such as Salinomycin, in anti-cancer research.

673 records 10/45 page Previous Next First page 上5页 678910 下5页 Last page